Functional inhibition of UQCRB suppresses angiogenesis in zebrafish

Biochemical and Biophysical Research Communications

Volumn 433, Issue 4, 2013, Pages 396-400

  Cho, Yoon Sun ^a   Jung, Hye Jin ^a   Seok, Seung Hyeok ^b   Payumo, Alexander Y ^c   Chen, James K ^c   Kwon, Ho Jeong ^a  

^a Yonsei University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Mitochondria; UQCRB; Zebrafish

Indexed keywords

UBIQUINOL CYTOCHROME C REDUCTASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENETICS; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; ZEBRA FISH;

AMINO ACID SEQUENCE; ANIMALS; BICYCLO COMPOUNDS; CARRIER PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, NONMAMMALIAN; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKDOWN TECHNIQUES; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; MORPHOLINOS; NEOVASCULARIZATION, PHYSIOLOGIC; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZEBRAFISH;

DANIO RERIO;

EID: 84876477776     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.02.082     Document Type: Article

References (24)

1. DiMauro S., Schon E.A. Mitochondrial respiratory-chain diseases. N. Engl. J. Med. 2003, 348:2656-2668.
2. Crivellone M.D., Wu M.A., Tzagoloff A. Assembly of the mitochondrial membrane system. Analysis of structural mutants of the yeast coenzyme QH2-cytochrome C reductase complex. J. Biol. Chem. 1988, 263:14323-14333.
3. de Lonlay P., Valnot I., Barrientos A., Gorbatyuk M., Tzagoloff A., Taanman J.W., Benayoun E., Chretien D., Kadhom N., Lombes A., de Baulny H.O., Niaudet P., Munnich A., Rustin P., Rotig A. A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat. Genet. 2001, 29:57-60.
4. Haut S., Brivet M., Touati G., Rustin P., Lebon S., Garcia-Cazorla A., Saudubray J.M., Boutron A., Legrand A., Slama A. A deletion in the human QP-C gene causes a complex III deficiency resulting in hypoglycemia and lactic acidosis. Hum. Genet. 2003, 113:118-122.
5. Lascorz J., Bevier M., Schonfels W.V., Kalthoff H., Aselmann H., Beckmann J., Egberts J., Buch S., Becker T., Schreiber S., Hampe J., Hemminki K., Forsti A., Schafmayer C. Polymorphisms in the mitochondrial oxidative phosphorylation chain genes as prognostic markers for colorectal cancer. BMC Med. Genet. 2012, 13:31.
6. Wrzeszczynski K.O., Varadan V., Byrnes J., Lum E., Kamalakaran S., Levine D.A., Dimitrova N., Zhang M.Q., Lucito R. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer. PLoS One 2011, 6:e28503.
7. Jung H.J., Shim J.S., Lee J., Song Y.M., Park K.C., Choi S.H., Kim N.D., Yoon J.H., Mungai P.T., Schumacker P.T., Kwon H.J. Terpestacin inhibits tumor angiogenesis by targeting UQCRB of mitochondrial complex III and suppressing hypoxia-induced reactive oxygen species production and cellular oxygen sensing. J. Biol. Chem. 2010, 285:11584-11595.
8. Lawson N.D., Weinstein B.M. Arteries and veins: making a difference with zebrafish. Nat. Rev. Genet. 2002, 3:674-682.
9. Cross L.M., Cook M.A., Lin S., Chen J.N., Rubinstein A.L. Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay. Arterioscler. Thromb. Vasc. Biol. 2003, 23:911-912.
10. Nasevicius A., Ekker S.C. Effective targeted gene 'knockdown' in zebrafish. Nat. Genet. 2000, 26:216-220.
11. Summerton J., Weller D. Morpholino antisense oligomers: design, preparation, and properties. Antisense Nucleic Acid Drug Dev. 1997, 7:187-195.
12. Tran T.C., Sneed B., Haider J., Blavo D., White A., Aiyejorun T., Baranowski T.C., Rubinstein A.L., Doan T.N., Dingledine R., Sandberg E.M. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. Cancer Res. 2007, 67:11386-11392.
13. Crawford A.D., Liekens S., Kamuhabwa A.R., Maes J., Munck S., Busson R., Rozenski J., Esguerra C.V., de Witte P.A. Zebrafish bioassay-guided natural product discovery: isolation of angiogenesis inhibitors from East African medicinal plants. PLoS One 2011, 6:e14694.
14. Lawson N.D., Weinstein B.M. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 2002, 248:307-318.
15. Wiens K.M., Lee H.L., Shimada H., Metcalf A.E., Chao M.Y., Lien C.L. Platelet-derived growth factor receptor beta is critical for zebrafish intersegmental vessel formation. PLoS One 2010, 5:e11324.
16. Childs S., Chen J.N., Garrity D.M., Fishman M.C. Patterning of angiogenesis in the zebrafish embryo. Development 2002, 129:973-982.
17. M. Westerfield, The Zebrafish Book: a Guide for the Laboratory Use of Zebrafish (Danio rerio), third ed., Eugene, OR, University of Oregon Press, 1995.
18. Soraya H., Esfahanian N., Shakiba Y., Ghazi-Khansari M., Nikbin B., Hafezzadeh H., Dizaji N.M., Garjani A. Anti-angiogenic effects of metformin, an AMPK activator, on human umbilical vein endothelial cells and on granulation tissue in rat. Iran. J. Basic Med. Sci. 2012, 15:1202-1209.
19. Tan B.K., Adya R., Chen J., Farhatullah S., Heutling D., Mitchell D., Lehnert H., Randeva H.S. Metformin decreases angiogenesis via NF-κB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1. Cardiovasc. Res. 2009, 83:566-574.
20. Ersoy C., Kiyici S., Budak F., Oral B., Guclu M., Duran C., Selimoglu H., Erturk E., Tuncel E., Imamoglu S. The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients. Diabetes Res. Clin. Pract. 2008, 81:56-60.
21. Phoenix K.N., Vumbaca F., Claffey K.P. Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model. Breast Cancer Res. Treat. 2009, 113:101-111.
22. Gong Y., Agani F.H. Oligomycin inhibits HIF-1α expression in hypoxic tumor cells. Am. J. Physiol. Cell Physiol. 2005, 288:C1023-C1029.
23. Richard D.E., Berra E., Pouyssegur J. Angiogenesis: how a tumor adapts to hypoxia. Biochem. Biophys. Res. Commun. 1999, 266:718-722.
24. Pathania D., Millard M., Neamati N. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism. Adv. Drug Deliv. Rev. 2009, 61:1250-1275.